Allianz SE VNA O.N.

Late 2021 — FY2021: Structured Alpha provision; dividend increase; share buy‑back

Allianz booked a large pre‑tax provision (~€3.7bn) related to AllianzGI U.S. Structured Alpha funds, reducing 2021 net income by ~€2.8bn. The group reported strong operating profit (~€13.4bn) and the Board proposed a dividend of €10.80/share. A €750m buy‑back was announced on 5 Aug 2021, with ~3.8m shares acquired by 22 Oct 2021. [2][1][4][11]

Markets viewed the results as proof of operational resilience but reacted to elevated legal and settlement risk. Sentiment shifted from pure "compounder" to "resilient but event‑risk" until legal clarity improved. The stock experienced headline‑driven volatility and a near‑term drawdown as investors re‑priced the one‑off provision and uncertainty.

Mar–Jun 2022 — Russia: cease new business; announced sale of majority stake (Interholding) and earnings hit guidance

After Russia's invasion of Ukraine, Allianz halted underwriting and investments in Russia in March 2022. On 3 June 2022 it announced the sale of a majority stake in its Russian operations to Interholding, with Allianz retaining 49.9%. Management warned of an expected profit hit of roughly €400m (reported ~€430m by some outlets). [18][20][19]

Investors saw this as a decisive de‑risking and reputational decision, accepting a near‑term earnings hit in exchange for political and legal de‑risking. Q1–Q3 2022 saw volatility and a downtrend driven by macro and geopolitical shock.

Nov 2022 — Russia deal regulatory delay

Allianz reported the planned Russia transaction faced regulatory delays in Russia, with the financial impact to be recognized in Q4 2022 or Q1 2023. [21]

Timing uncertainty extended headline risk but was treated by many investors as temporary execution timing rather than a structural problem. The stock moved in a range while awaiting regulatory clearance.

Mar 2022–Nov 2023 — multi‑tranche buybacks and share count reduction

Allianz executed multi‑tranche buybacks: €1.0bn (8 Mar–15 Jul 2022), €1.0bn (21 Nov 2022–17 Mar 2023) and €1.5bn (29 May–24 Nov 2023). On 28 Nov 2023, 6,912,156 repurchased shares were redeemed, reducing issued shares from 403,313,996 to 391,718,983. [14]

Capital returns became central to the equity story. Management used buybacks to offset headline items and support EPS; investor sentiment gradually improved as buybacks signalled confidence in valuation. [14] The stock stabilized in late 2022 followed by a gradual uptrend through 2023 as buybacks and improving results supported momentum. [13]

Feb 2023 — FY2022: record operating profit; dividend increase and capital‑management clarity

Allianz reported record operating profit for 2022 and proposed a dividend of €11.40/share (≈+5.6% vs 2021) while reaffirming capital‑management measures including buybacks. [12][9]

Results shifted perception back toward a resilient, diversified insurance compounder with an explicit shareholder‑return bias. The stock broke out into an accelerating uptrend as fundamentals and capital returns aligned.

H1–H2 2023 — Russia disposal: accounting loss but prior provisioning limited cash impact

Group reporting in 2023 showed a loss on disposal and control of the Russian business (reported ~€435m). Allianz noted that most of the cash loss had been covered by a reserve set up in Q4 2022, so the net cash impact in H1 2023 was materially mitigated. [16][19]

The exit was ultimately viewed as prudently managed; initial volatility gave way to muted market impact once provisioning and reserve mechanics became clear. [16] The stock experienced a short‑lived sell‑off then stabilized as investors digested the accounting and cash‑flow implications.

Oct 2023 — leadership continuity (CEO mandate extended) amid recovery

The Supervisory Board extended CEO Oliver Bäte's mandate (renewal announced Oct 2023) while finance‑chief movement to Generali clarified executive reshuffle. [38][48][46]

Continuity at CEO level removed a notable governance overhang and strengthened investor confidence in execution. Management stability supported the capital‑returns story and was supportive to sentiment.

22 Feb 2024 — €1bn buyback resolved and dividend‑policy amendment

Allianz resolved a new share buyback program of up to €1.0bn and announced an amendment to its dividend policy (22 Feb 2024). [26]

This reinforced the shareholder‑friendly framework; investors interpreted it as sustained prioritization of returns alongside operational cash generation. The stock consolidated before resuming its uptrend as markets priced higher cash returns.

Dec 2024 — Capital Markets Day: medium‑term targets to 2027

At the Capital Markets Day (Dec 2024) Allianz published priorities and medium‑term financial targets through end‑2027. [36][39]

The event provided strategic clarity; investors began to re‑rate execution risk lower as targets and buyback and dividend trajectories were formalized. The stock ranged as targets were absorbed, setting up for a later breakout.

27 Feb 2025 — new €2.0bn buyback resolved (start March 2025)

Allianz resolved a new share buyback program of up to €2.0bn (to start March 2025 and to be completed by 31 Dec 2025); all repurchased shares to be cancelled. [22][24][25]

This marked a clear step‑up in capital returns and signalled management's conviction on valuation, shifting investor framing toward total‑return and yield‑plus‑growth. The stock rallied and continued its uptrend through 2025 as buyback execution and operating performance supported the price.

12–13 Mar 2026 — Board changes announced; new €2.5bn buyback launched (Mar 13, 2026)

Allianz announced changes to its Board of Management (12 Mar 2026) and on 13 Mar 2026 launched a new share buyback program of up to €2.5bn (program start 13 Mar 2026; to be finalized by 31 Dec 2026), with repurchased shares to be cancelled. [50][14]

Management refresh combined with the largest recent buyback reinforced the capital‑return narrative and signalled continued prioritization of shareholder value. [14][50] The stock moved into a strong uptrend into 2026, supported by aggressive, cancellable buybacks and improving fundamentals.

Apr 2026 — retail‑base milestone

Allianz reported in Apr 2026 that it had surpassed one million direct private shareholders. [39]

Broader retail ownership increased liquidity and retail interest; the shareholder base diversification was noted as supportive for secondary market demand. [39] Momentum sustained the rally into mid‑2026.

11 Jul 2026 — market level (latest price)

ALV.XETRA latest price 421.6.

By mid‑2026 the stock had re‑rated from the 2021/2022 headline‑driven troughs on the back of restored operating momentum, progressive dividend increases and a succession of large cancellable buybacks. Investor framing had shifted to a shareholder‑return‑focused compounder. [12][14][22] The stock reflected an extended rally and new highs relative to the 2021–2022 period, a multi‑year uptrend into 2026.